Johnson & Johnson COVID vaccine: FDA adds warning of rare reaction risk

Johnson & Johnson COVID vaccine: FDA adds warning of rare reaction risk

The reports of 100 people developing Guillain-Barré syndrome represent a tiny fraction of the nearly 13 million Americans who have received the one-dose vaccine.

8
Upvote
Save

Comments

Write a comment

*